PTA

L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of a European circular economy

Retrieved on: 
木曜日, 5月 30, 2024
PET, Partnership, Ellen, PTA, Recycling, MacArthur Foundation, Depolymerization, CO2, MEG, Carreau du Temple, Textile, LCA

The 100% recycled PET bottle from CARBIOS' enzymatic depolymerization process was made with a European value chain committed to responsible consumption of sustainable materials.

Key Points: 
  • The 100% recycled PET bottle from CARBIOS' enzymatic depolymerization process was made with a European value chain committed to responsible consumption of sustainable materials.
  • The bottle’s production began with the local supply of PET waste (already collected, sorted and prepared) to the CARBIOS industrial demonstrator in Clermont-Ferrand, France.
  • Emmanuel Ladent, CEO, CARBIOS : « CARBIOS' innovation accelerates the transition to a circular economy by offering an alternative to petro-sourced PET and a circular PET recycling solution that reduces CO2 emissions by 57%.
  • We're seeing strong demand for high-quality recycled PET which can be used to produce the same applications as with virgin PET.

Global Helium Corp. Confirms Positive 10-08 Well Results, Further Drilling Planned and Acquisition of New Helium Prospect

Retrieved on: 
水曜日, 5月 22, 2024
PTA, Helium, Pressure, HECO, Agreement, OTC, NAH, Technische Universität Darmstadt, Consultant, Medicine Hat, Option, Oil

Helium concentrations from the Beaverhill Lake zone were 0.56% – 0.68% based on several analyzed gas samples from the well, confirming that the 10-08 well represents HECO’s second commercially viable opportunity.

Key Points: 
  • Helium concentrations from the Beaverhill Lake zone were 0.56% – 0.68% based on several analyzed gas samples from the well, confirming that the 10-08 well represents HECO’s second commercially viable opportunity.
  • The PTA indicated the reservoir appears expansive and productive, with no discernible depletion in reservoir pressure or demarcation of reservoir boundaries.
  • Moreover, the PTA revealed an absolute open flow potential of 8.05 million standard cubic feet per day (MMscf/d).
  • The Company has successfully acquired eight sections of land in Northern Alberta, situated within a region prospective for helium.

OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China

Retrieved on: 
水曜日, 4月 24, 2024
Tricuspid valve, FDA, TMVR, Hope, Hospital, Percutaneous coronary intervention, NMPA, Safety, Valvular heart disease, OrbusNeich, PCI, TAVR, Patient, PTA, Zhongshan Hospital, Fudan University, Cardiology, Aortic stenosis, Clinical trial, Quality of life, Medical device

The CE-marked medical device was named a Breakthrough Device and an Innovative Medical Device by the FDA in the United States and NMPA in China, respectively.

Key Points: 
  • The CE-marked medical device was named a Breakthrough Device and an Innovative Medical Device by the FDA in the United States and NMPA in China, respectively.
  • It has effectively treated a 56-year-old patient with severe tricuspid regurgitation, marking the commencement of the clinical trial across Mainland China.
  • Led by principal investigator Prof. Ge Junbo, Academician Zhongshan Hospital, Fudan University, and his team, the clinical trial aims to assess the safety and efficacy of TricValve.
  • Mr. Peter Peh, General Manager of OrbusNeich P&F, said, "We are pleased to see TricValve moving into clinical trial, marking the first successful implantation of a percutaneous transcatheter bicaval device in a patient by cardiologists in Mainland China, to address severe tricuspid valve regurgitation.

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks

Retrieved on: 
水曜日, 5月 8, 2024
Hearing, Safety, Food, ABR, Regeneron Pharmaceuticals, Cell, Research, Gold, Sound, PTA, Society, Gene, Otorhinolaryngology, Child, Ear, Orphan drug, European Medicines Agency

TARRYTOWN, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11 months of age) within 24 weeks, and initial hearing improvements were observed in a second child (dosed at 4 years of age) at a 6-week assessment. Both children were born with profound genetic deafness due to variants of the otoferlin gene, and the child dosed at 11 months of age is one of the youngest in the world to receive a gene therapy for genetic deafness. The results are from the ongoing Phase 1/2 CHORD trial, which is currently enrolling infants and children and were detailed during an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) annual conference.

Key Points: 
  • The surgical procedure leverages the same approach used for cochlear implants, which is amenable for use in young infants.
  • Hearing improvements were assessed by pure tone audiometry (PTA) and auditory brainstem response (ABR).
  • At baseline, both participants had no behavioral (PTA) or electrophysiological (ABR) responses at maximum sound levels (≥100 dB).
  • The potential use of DB-OTO for otoferlin-related hearing loss is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.

AdvoCare® Honors Richardson ISD Teachers and Staff During Teacher Appreciation Week

Retrieved on: 
水曜日, 5月 8, 2024
Preschool, Food, Beverage, Women, Retail, Parenting, Men, Children, Family, Electronic Commerce, Consumer, Fitness & Nutrition, Technology, General Health, Health, Other Education, Specialty, Primary, Secondary, Education, CMO, GO, George, School, Lake Highlands High School, Sambucus, RISD, PTA, AdvoCare, Harmony, Multimedia, Richardson Independent School District, Tutoring

AdvoCare International, LLC , a health and wellness e-commerce company, actively sought opportunities to support the dedicated educators within its community showing appreciation to them across three campuses within Richardson ISD (RISD) during Teacher Appreciation Week, May 6-10.

Key Points: 
  • AdvoCare International, LLC , a health and wellness e-commerce company, actively sought opportunities to support the dedicated educators within its community showing appreciation to them across three campuses within Richardson ISD (RISD) during Teacher Appreciation Week, May 6-10.
  • AdvoCare donated a total of $3,000 to three schools within RISD – Forest Meadow Junior High, Spring Creek Elementary, and Lake Highlands High School.
  • "By supporting Richardson ISD teachers and staff, we aim to express our heartfelt gratitude for their unwavering dedication to shaping our future generations.
  • AdvoCare will also accept nominations via their @AdvoCare Instagram to fulfill teachers’ Amazon Wish Lists, granting up to $500 per winner.

A Role Model in Her Community: Regions Bank Branch Manager Honored for Making an Impact on Others

Retrieved on: 
水曜日, 4月 24, 2024
Professional Services, Philanthropy, Other Consumer, Consumer, Other Philanthropy, Finance, Banking, Education, Service award, Cancer, National Volunteer Week, Hope, Teaching, Heart, Happiness, Lunch, Human, Life, Regions Financial Corporation, PTA, Bank, Birmingham Civil Rights Institute, Commerce, Multimedia, Student, The Front Porch, MIT

Regions Bank on Wednesday announced Kascia Polk, manager of Regions’ Villa Rica, Georgia, branch, has been awarded the 2024 Lee Ann Petty Heart of Service Award, Regions’ highest honor for community involvement.

Key Points: 
  • Regions Bank on Wednesday announced Kascia Polk, manager of Regions’ Villa Rica, Georgia, branch, has been awarded the 2024 Lee Ann Petty Heart of Service Award, Regions’ highest honor for community involvement.
  • Longtime Regions associate Lee Ann Petty served as volunteer services coordinator in Regions’ Community Affairs division.
  • Regions is proud to honor Kascia Polk with the award that pays tribute to Petty’s legacy.
  • “I’m honored and humbled to be recognized with the Lee Ann Petty Heart of Service Award,” Polk said.

Southeast Seattle Schools Collaborative Fundraiser seeks community support to raise funds

Retrieved on: 
日曜日, 4月 21, 2024
SPS, Learning, School, Parent, Student, Seattle Public Schools, Friends, Washington State, Lotus, PTA, PTAS, Patent, Social justice, K-8, Tutoring

SEATTLE, April 21, 2024 /PRNewswire-PRWeb/ -- The fourth annual move-a-thon fundraiser, led by Southeast Seattle Schools Fundraising Alliance, will kick off on Monday, April 22, and run (literally!)

Key Points: 
  • SEATTLE, April 21, 2024 /PRNewswire-PRWeb/ -- The fourth annual move-a-thon fundraiser, led by Southeast Seattle Schools Fundraising Alliance, will kick off on Monday, April 22, and run (literally!)
  • ) through Friday, May 3, to benefit approximately 7000 students attending 17 elementary, K-8 and middle schools in District 7 of Seattle Public Schools.
  • The collaborative fundraising effort aims to raise $500,000 for schools who have historically been unable to raise the kind of funds typically generated by parent organizations elsewhere in the district.
  • This year, the Southeast Seattle Schools Fundraising Alliance will again engage students in participating in a bingo board-based move-a-thon to raise money.

GCC Polyethylene Terephthalate Market Analysis Report 2024: PET's Role in Eco-Friendly Packaging Solutions and Versatility in Automotive Applications - Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
火曜日, 3月 26, 2024
Packaging, Recycling, Chemicals, Plastics, Automotive Manufacturing, Environment, Manufacturing, MEG, PTA, Urbanization, Growth, Sport, Application, Dow Chemical Company, International, COVID-19, SABIC, PET, Transport, Food, Private sector, RPET, Ethylene glycol, Supply, GCC, Vision 2030, Tourism, Drink, Water, Compound annual growth rate, Polyethylene terephthalate, JBF, Food safety, Food industry, Bottled water

GCC PET market demand is forecasted to grow at a CAGR of 5.30% over the projected period of 2024-2029.

Key Points: 
  • GCC PET market demand is forecasted to grow at a CAGR of 5.30% over the projected period of 2024-2029.
  • GCC PET supply is expected to reach 3.61 million ton by 2029, while GCC PET demand in 2023 stood at 2.20 million ton.
  • Polyethylene Terephthalate (PET), formed by combining purified terephthalic acid (PTA) or dimethyl terephthalate with modified ethylene glycol, exhibits notable impact resistance and ensures food safety.
  • The GCC Polyethylene Terephthalate (PET) market is characterized by a moderately concentrated landscape with several established players vying for market share.

Sensorion Reports Full-Year 2023 Financial Results and Business Update

Retrieved on: 
木曜日, 3月 14, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Bioreactor, Malignancy, Cell, Chemistry, Patient, Orphan, Good manufacturing practice, Health care, CMC, G&A, Molecular biology, Quality of life, European Medicines Agency, Science, Clinical trial, Cisplatin, Therapy, Hertz, Neoplasm, CIO, Congress, Huber loss, Partnership, Ageing, EMA, Hearing loss, GMP, Cochlea, Biochemistry, Safety, Language, Perilymph, G7, Medication, Control, AAV, PTA, IHC, Pasteur Institute, CDMO, Communication, Genetics, Research, KOL, Ear, POC, FDA, Ototoxicity, GJB2, ABR, CTA, ANSM, Audiogram, Platinum, Investment company, Congenital hearing loss, Pathology, Presbycusis, Hearing, Pharmaceutical industry

Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today reports full-year 2023 financial results and business update.

Key Points: 
  • Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today reports full-year 2023 financial results and business update.
  • Nawal Ouzren, Chief Executive Officer of Sensorion, said: “Over the past months, Sensorion has successfully achieved all the major milestones on its roadmap.
  • In the first half of 2023, Sensorion achieved a major development milestone by completing the preclinical package, and successfully producing the GMP dual AAV SENS-501 clinical batches at 200L scale.
  • On April 6, 2023, Sensorion announced the candidate selection for GJB2-GT during its gene therapy focused R&D Day.

BioSkryb Launches New Whole Genome and Transcriptome Core Kits to Accelerate Single-Cell Multiomics

Retrieved on: 
水曜日, 3月 13, 2024
Health Technology, Other Health, Technology, Oncology, General Health, Medical Devices, Neurology, Other Technology, Cardiology, Science, Biotechnology, Software, Other Science, Health, Research, PTA, Genome, Gene expression, Transcriptome, DNA, RNA, Figure skating jumps, Marketing, Workflow, Data, Genomics, SVS, WGA, Antibiotics

BioSkryb Genomics , a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, which are now available to U.S. and international customers.

Key Points: 
  • BioSkryb Genomics , a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, which are now available to U.S. and international customers.
  • As part of these new kit configurations, total workflow time has been reduced to under eight hours for both products.
  • “These new core kits provide researchers with an optimized and validated workflow that delivers industry-leading single-cell multiomic performance,” said Suresh Pisharody, CEO, BioSkryb.
  • The ResolveOME Whole Genome and Transcriptome Single-Cell Core Kit leverages its PTA-based WGA technology to couple each single cell’s whole genome with its full-length whole transcriptome.